Hepatitis C virus nonstructural 3/4A protein dampens inflammation and contributes to slow fibrosis progression during chronic fibrosis in vivo

Autor: Bansal, Ruchi, Frelin, Lars, Brenndörfer, Erwin Daniel, Storm, G, Prakash, Jai, Sällberg, Matti, Pharmaceutics, Sub Drug targeting
Přispěvatelé: Pharmaceutics, Sub Drug targeting, Biomaterials Science and Technology, Faculty of Science and Technology
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Liver Cirrhosis
Male
viruses
lcsh:Medicine
Gene Expression
Hepacivirus
Viral Nonstructural Proteins
medicine.disease_cause
Biochemistry
Mice
Fibrosis
Transgenes
lcsh:Science
Carbon Tetrachloride
Liver injury
Medicine(all)
Multidisciplinary
Agricultural and Biological Sciences(all)
Intracellular Signaling Peptides and Proteins
virus diseases
medicine.anatomical_structure
Liver
Hepatocyte
Acute Disease
Disease Progression
medicine.symptom
Research Article
Genetically modified mouse
Hepatitis C virus
Mice
Transgenic

Inflammation
Biology
IR-95975
medicine
Animals
Cell Proliferation
Biochemistry
Genetics and Molecular Biology(all)

Macrophages
Regeneration (biology)
lcsh:R
Hepatitis C
Chronic

biochemical phenomena
metabolism
and nutrition

medicine.disease
digestive system diseases
Mice
Inbred C57BL

Apoptosis
Chronic Disease
Immunology
Hepatocytes
Mice
Inbred CBA

lcsh:Q
Carrier Proteins
METIS-310566
Genetics and Molecular Biology(all)
Zdroj: PLoS One, 10(6). Public Library of Science
PLoS ONE, 10(6):e0128466. Public Library of Science
PLoS ONE
PLoS ONE, Vol 10, Iss 6, p e0128466 (2015)
ISSN: 1932-6203
Popis: HCV infection typically induces liver injury and inflammation, which appears to be responsible for the associated fibrogenesis. To date, the mechanism underlying the different rates of disease progression remains unclear. The aim of the study is to understand the possible role of the HCV non-structural (NS) 3/4A protein in the fibrosis progression. We used NS3/4A-expressing transgenic mice (NS3/4A-Tg) to accomplish the goals of the study. Different stages of liver fibrosis were induced in wild-type and NS3/4A-Tg mice by single carbon tetrachloride (acute) or multiple injections for 4 (intermediate) or 8 (chronic) weeks. Fibrotic parameters, inflammatory responses and hepatocyte turnover were extensively examined. Hepatic expression of HCV NS3/4A did not induce spontaneous liver damage. However, NS3/4A expression exerted contrasting effects during acute and chronic liver damage. During early fibrogenesis and intermediate fibrosis (4 weeks), NS3/4A-Tg mice exhibited enhanced liver damage whereas reduced fibrosis was observed in NS3/4A-Tg during chronic liver fibrosis (8 weeks). Furthermore, attenuated inflammation was observed in NS3/4A-Tg during chronic fibrosis with increase in M2 macrophages, hepatocyte proliferation, decreased hepatocyte apoptosis and decreased ductular reaction. In conclusion, during early fibrogenesis, HCV NS3/4A contributes to liver damage. While, during chronic liver fibrosis, NS3/4A dampens inflammation and induces hepatocyte regeneration thereby contributing to slow fibrosis progression to promote its survival or persistence.
Databáze: OpenAIRE